Become a Fish Fan

Earlier this year I wrote a blog about the benefits of a Mediterranean diet – a big component of this being regular consumption of fish – for those with rheumatoid arthritis. Anyone concerned about their risk of multiple sclerosis will also be interested to hear about how a Mediterranean diet brings benefits. Including fish in…

Introducing New Prostate Cancer Treatment, Available from BioPlus

A new medication has joined the ranks of potential treatment for prostate cancer. The FDA recently approved Janssen’s Erleada™ (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but continues to grow despite treatment with hormone therapy (castration-resistant). BioPlus Specialty Pharmacy can help patients get started with Erleada and support…

Crohn’s Disease: Heading Toward its 100th Birthday

Could a cure for Crohn’s disease be in the future? There are several research directions that are moving forward with hopeful results, although a “cure” appears to remain an unsatisfying way in the distance. Crohn’s disease – as a specific type of inflammatory bowel disease – was first described back in 1932. As we head…

Manly MS Resistance?

Multiple sclerosis is often thought of as more of a female disease. This is because women are twice or even three times as likely to develop multiple sclerosis compared to men. This gender difference has led researchers to explore the influence of sex hormones in this disease. Testosterone – which men typically have in higher…

Hepatitis C and Diabetes: A Complicated Relationship

Guest blog by: Erica Yelton, Pharm.D., CSP, Pharmacy Center Manager, BioPlus Specialty Pharmacy Hepatitis C and diabetes are both prevalent, global diseases with long-term implications in terms of morbidity and mortality. The World Health Organization reports that 170 million people are infected with hepatitis C and 347 million people suffer with diabetes. Most studies show…

The Prostate Cancer Toolkit

For men, prostate cancer remains the second most common type of cancer. Only skin cancer is more prevalent. Over the course of his lifetime, one in every seven men will develop prostate cancer and one in 39 men will die of prostate cancer. The difference in those numbers means that lots of men are surviving…

Personalizing Crohn’s Disease Treatment

Guest blog by: Marianne Shenouda, Pharm.D., Clinical Pharmacy Specialist, BioPlus Specialty Pharmacy Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, are chronic inflammatory diseases of the bowel. These diseases can develop as a result of genetic or environmental factors, such as smoking, diet, or any alteration of the normal human gut flora. These factors…

Rheumatoid Arthritis: What Should I Eat?

When it comes to rheumatoid arthritis, the foods one eats or avoids can actually affect the symptoms of this autoimmune disease. Dietary interventions can be a useful compliment to pharmacological treatment of rheumatoid arthritis. What it mostly comes down to are certain foods that either promote or discourage inflammation. Overall, a type of diet known…

Understanding NAFLD and NASH

Guest blog by: Monica Morgan, Pharm.D., CSP As a specialty pharmacy that works with many patients during treatment for liver diseases, it’s not surprising that questions about nonalcoholic fatty liver disease (NAFLD) come up in our line of work. Although hepatitis C is our primary liver focus, both hepatitis C and NAFLD rank as the…

Energy Drink Ingredient’s Surprising Role in Multiple Sclerosis

The amino acid taurine has caught the attention of multiple sclerosis researchers. Amino acids are the building blocks of protein. Taurine can be found in many places throughout the body, such as the cardiovascular system where it plays an essential role in heart function, but it also shows up in the central nervous system. Taurine…

HCV and Children

Hepatitis C screening programs and treatment outreach tend to focus on three key populations: Baby Boomers, IV drug users, and prison populations. This is understandable, since rates of infection are notable in these high-risk groups. However, children infected with the hepatitis C virus (HCV) deserve attention, too. Of the more than 4 million people with…

Breast Cancer Treatment Options Expanding

Targeted cancer therapies aim to best match the treatment to specific characteristics of cancer cells. Increasingly, breast cancer treatment is based on targeted therapy medications. With targeted therapy, the harm to healthy cells can be lessened and thus side effects can be less severe than from traditional chemotherapy. Earlier this month, the FDA approved a…

The Rheumatoid Arthritis Gender Gap

Rheumatoid arthritis skews very female in the 1.5 million Americans with this disease. There are three women with rheumatoid arthritis to every one man with this autoimmune condition. Furthermore, the disease tends to develop at younger ages in women than in men and also can cause more severe symptoms in women. While the exact reasons…

Cost Concerns

The financial hardships of a serious illness can be daunting. Even for those with health insurance, the medical bills and pharmacy costs can accumulate, along with a potential loss of income while treating and recovering from a disease. In a recent survey of nearly 500 people after successful colorectal cancer treatment, financial challenges were reported…

A Faster Route to Treatment

Psoriasis goes more than skin deep. Although primarily thought of as a skin disease, psoriasis develops into psoriatic arthritis in approximately 30% of psoriasis patients. Psoriatic arthritis, in turn, often complicates diagnosis and treatment. Meanwhile the disease process can be heading toward impaired function and a compromised quality of life. For many years, the prevailing…

A Look Back at 2017’s FDA Approvals

2018 is poised to be a promising year in terms of new medications the U.S. Food and Drug Administration (FDA) will be considering for approval. This pipeline of potential new specialty pharmacy medications includes a new psoriasis medication, a few new multiple sclerosis medications, and several medications for oncology. In terms of new treatment options,…

Patient Education: Hepatitis C Testing Process

Patients receiving hepatitis C screenings often have questions about the testing process. This blog can be shared with your patients to help them understand each step of what can be a stressful time. Q: Do I really need to be tested for the hepatitis C virus? A: Testing for the hepatitis C virus (HCV) is…

Taltz: New Tool for Psoriatic Arthritis

Psoriasis affects 7.5 million Americans, with 18-42% of these people later developing psoriatic arthritis. This month, the U.S. Food and Drug Administration (FDA) approved a new treatment option for this difficult condition. Ixekizumab (Taltz) from Eli Lilly and Company is now approved as an injection for the treatment of adults with active psoriatic arthritis. Taltz…